Physician profile
Alisha Basnet
NPI 1497522858
$2,614.89
in general payments reported to CMS, 2019-2025
18 companies · $1,664 in 2025
The $1,664 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $951 · 2025: $1,664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,543 · Education: $72.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,542.89 |
| Education | $72.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $343.27 | 2024-2025 | Opzelura, Opzelura |
| Abbvie INC. | $338.39 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $315.44 | 2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $241.18 | 2024-2025 | |
| Janssen Biotech, INC. | $216.66 | 2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $216.33 | 2024 | Sotyktu |
| Genzyme Corporation | $184.84 | 2024-2025 | |
| Lilly USA, LLC | $181.32 | 2024-2025 | Ebglyss, Taltz, Olumiant |
| Amgen INC. | $134.18 | 2024 | Otezla |
| Astrazeneca Pharmaceuticals LP | $127.00 | 2024 | Saphnelo |
| Ucb, INC. | $95.50 | 2024-2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $69.59 | 2024 | Libtayo, Dupixent |
| Mayne Pharma Commercial LLC | $55.27 | 2025 | |
| Sun Pharmaceutical Industries INC. | $27.30 | 2024 | |
| Galderma Laboratories, L.P. | $20.18 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.28 | 2024 | Jublia, Cabtreo, Arazlo |
| Journey Medical Corporation | $15.21 | 2024 | |
| Organon LLC | $14.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alisha Basnet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.